What did Hims & Hers Health, Inc. pay for Eucalyptus?

Hims & Hers Health, Inc. acquired Eucalyptus for $1.15B in 2026, equivalent to 2.60x revenue. Target revenue was approximately $450.0M.

What does Eucalyptus do?

Eucalyptus is a healthcare it business.

What multiple did Hims & Hers Health, Inc. pay for Eucalyptus?

2.60x revenue, based on disclosed deal value of $1.15B and disclosed financials.

M&A TRANSACTION · 2026

Eucalyptus acquired by Hims & Hers Health, Inc.

$1.15B· 2.60x revenue

Target

Eucalyptus

Acquirer

Hims & Hers Health, Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$450.0M

EBITDA

—

Deal Value

$1.15B

EV/EBITDA

—

Context

This $1.15B acquisition of Eucalyptus by Hims & Hers Health, Inc. sits in the healthcare it sub-vertical. Hims & Hers Health, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare It strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Eucalyptus acquisition.

Citation: ExitValue.ai. (2026). Eucalyptus acquired by Hims & Hers Health, Inc.. https://exitvalue.ai/deals/eucalyptus-acquired-by-hims-hers-health-inc-hc-2026-0001